The objective was to assess the efficacy of intratympanic dexamethasone in treatment of sensorineural hearing loss at lower frequencies (LFSHL). The design is a prospective study. Eleven female and three male patients with LFSHL were included in this study. They were evaluated with pure-tone audiometry, acoustic admittance, transient evoked otoacoustic emission, and glycerol test. Seven, four, and three patients were seen within the mean of 2.86 ± 1.35 (1–5), 18.25 ± 2.36 (15–20), and 750 ± 700 (60–1,460) days from onset of LFSHL, respectively. They were treated with daily intratympanic dexamethasone (ITD) injection and reviewed with repeated daily audiograms during the intratympanic treatment. As complementary treatment, they were given oral prednisolone 1 mg/kg (maximum 60 mg), with 10 mg decreasing doses for every 3 days. Results were compared with their unaffected ear. The mean ± SD hearing level at 0.125 up to 1.5 kHz improved from 64.29 ± 19.18 to 25.93 ± 13.54 (P < 0.001), pure tone average improved from 62.7 ± 25.7 to 22.9 ± 17.8 (P < 0.001), speech reception thresholds improved from 34.6 ± 29.45 to 17.5 ± 16.38 (P = 0.028), speech discrimination scores improved from 65.7 ± 39.8 to 84.6 ± 24.7% (P = 0.024) with treatment. Complete recovery in 10 of 14 patients, partial recovery in 3 patients, was achieved after therapy; and in one patient the situation was unchanged. The mean hearing level at 0.125 up to 1.5 kHz was elevated from 45.6 ± 17.5 to 9.1 ± 10.3 dB (P < 0.001) when compared with unaffected ear. The mean recovery rate was 77.9 ± 25.3%. ITD is an effective therapy for LFSHL.
Hearing loss Intratympanic Steroid Low frequency
This is a preview of subscription content, log in to check access.
Imamura S, Nozawa I, Imamura M, Murakami Y (1997) Clinical observations on acute low-tone sensorineural hearing loss. Ann Otol Rhinol Laryngol 106:746–750CrossRefPubMedGoogle Scholar
Kitajiri SI, Tabuchi K, Hiraumi H, Hirose T (2002) Is corticosteroid therapy effective for sudden-onset sensorineural hearing loss at lower frequencies? Arch Otolaryngol Head Neck Surg 128:365–367CrossRefPubMedGoogle Scholar
Yamasoba T, Kikuchi S, Sugasawa M, Yagi M, Harada T (1994) Acute low-tone sensorineural hearing loss without vertigo. Arch Otolaryngol Head Neck Surg 120:532–535CrossRefPubMedGoogle Scholar
Abe T (1982) Acute sensorineural hearing loss in low tone frequencies. Otolaryngol Tokyo 54:385–392Google Scholar
Fuse T, Aoyagi M, Funakubo T, Sakakibara A, Yoshida S (2002) Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL J Otorhinolaryngol Relat Spec 64:6–10. doi:10.1159/000049079CrossRefPubMedGoogle Scholar
Chandrasekhar SS, Rubinstein RY, Kwartler JA et al (2000) Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 122:521–528. doi:10.1016/S0194-5998(00)70094-5PubMedGoogle Scholar
Bachmann G, Su J, Zumegen C, Wittekindt C, Michel O (2001) Permeability of the round window membrane for prednisolone-21-hydrogen succinate. Prednisolone content of the perilymph after local administration vs. systemic injection. HNO 49:538–542. doi:10.1007/s001060170078CrossRefPubMedGoogle Scholar
Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A et al (2006) Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134:940–945. doi:10.1016/j.otohns.2005.03.081CrossRefPubMedGoogle Scholar
Okuno T, Sando I (1987) Localization, frequency and severity of endolymphatic hydrops and the pathology of the labyrinthine membrane in Meniere’s disease. Ann Otol Rhinol Laryngol 96:438–445CrossRefPubMedGoogle Scholar
Toru S, Michiko N, Atsushi M, Akiko Y, Tomonori T, Masafumi S (2003) Three cases of cochleosaccular endolymphatic hydrops without vertigo revealed by furosemide-loading vestibular evoked myogenic potential test. Otol Neurotol 24:807–811. doi:10.1097/00129492-200309000-00019CrossRefGoogle Scholar